MTOR and liver dysplastic nodule: Furthermore, treated mice also had proof of AMP-activated protein kinase activation which inhibits the mammalian target of rapamycin (mTOR) pathway, an important factor in the development of DN and an inhibitor of autophagy (Zhang et al., 2014).